About two years from now, Juno Therapeutics ($JUNO) plans to be settling in at its new headquarters at 400 Dexter Avenue North in Seattle. Alexandria Real Estate, which specializes in building biotech space, is constructing a new building at the site and has reserved 80,000 square feet of office/lab space for Juno, which also gets an option on adding additional space as needed. Juno--one of the hottest biotechs in the industry with a special focus on CAR-T--is getting $145 a foot for tenant improvements with the lease starting out at $3.8 million a year. Statement